Press Releases

 
Press Releases
  Date Title View
Mar 22, 2017
ALBANY, N.Y., March 22, 2017 /PRNewswire/ -- AMRI, a global contract research, development and manufacturing organization that has been working with the life sciences industry to improve patient outcomes and quality of life for more than 25 years, has been recognized for its excellence as a contract manufacturing organization (CMO). AMRI has b...
Mar 3, 2017
ALBANY, N.Y., March 3, 2017 /PRNewswire/ -- Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, President and Chief Executive Officer, will present at the Barclays Global Healthcare Conference on Thursday, March 16, 2017 at 10:45 a.m. ET. A live audio webcast of the presentation can be accessed at AMRI's Investor Re...
Feb 21, 2017
ALBANY, N.Y., Feb. 21, 2017 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced that it has entered into an agreement with the pharmaceutical group Ferrer  and Accord Healthcare, Inc. ("Accord Healthcare") to jointly develop and manufacture an undisclosed complex parenteral drug product for registration and subsequent commercialization in the Unite...
Feb 21, 2017
ALBANY, N.Y., Feb. 21, 2017 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today reported financial and operating results for the fourth quarter and full year ended December 31, 2016 and provided an outlook for 2017. Highlights: Fourth quarter total revenue of $191.3 million, up 51% from 2015 Full year total revenue of $570.5 million, up...
Feb 15, 2017
ALBANY, N.Y., Feb. 15, 2017 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today announced it will issue fourth quarter and full year 2016 financial results before the opening of the market on Tuesday, February 21, 2017.  Following the release of its results, the company will host a conference call and simultaneous audio webcast at 8:30 a.m. ET. The co...
Feb 7, 2017
ALBANY, N.Y., Feb. 7, 2017 /PRNewswire/ -- AMRI (NASDAQ: AMRI), a global contract research and manufacturing organization working to improve patient outcomes and quality of life, has entered an alliance with Bruker Daltonics and HighRes Biosolutions to develop new applications for using high throughput mass spectrometry (MS) for drug discovery. ...
Jan 19, 2017
Dec 13, 2016
ALBANY, N.Y., Dec. 13, 2016 /PRNewswire/ -- Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, AMRI's President and Chief Executive Officer, will present at the 35th Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2016 at 10:30 a.m. PT, with a question and answer session to follow at 11:00 a.m. P...
Dec 1, 2016
COSTA MESA, CA / ACCESSWIRE / December 1, 2016 / NEMUS Bioscience, Inc. (NMUS) announced that work performed in conjunction with its API contract developer and manufacturer, Albany Molecular Research Inc. (NASDAQ:AMRI), resulted in a synthetic pathway to manufacture the clinical-grade proprietary prodrug tetrahydrocannabinol-valine-hemisuccinate (T...
Nov 29, 2016
ALBANY, N.Y., Nov. 29, 2016 /PRNewswire/ -- AMRI (NASDAQ: AMRI) announced today that it has entered into a multi-year supply agreement for an undisclosed product with Shire US Manufacturing, Inc. which product has been in AMRI's portfolio through the required stages of development.  Shire plc, is a leading global biotechnology company focused on de...
Page:
1
... NextLast
= add release to Briefcase